Table 2.
Luo et. al. | This research | ||
---|---|---|---|
|
[%] |
[%] |
n |
Health Status |
43.72 |
45.04 |
318 |
Disease, Symptom and Sign |
29.21 |
22.52 |
159 |
Pregnancy-related activity |
5.17 |
5.24 |
37 |
Neoplasm status |
3.67 |
3.40 |
24 |
Disease stage |
2.20 |
2.27 |
16 |
Allergy |
2.15 |
5.95 |
42 |
Organ or tissue status |
0.73 |
5.38 |
38 |
Life expectancy |
0.59 |
0.28 |
2 |
Treatment or Health Care |
20.74 |
17.56 |
124 |
Pharmaceutical substance or drug |
12.84 |
7.37 |
52 |
Therapy or surgery |
7.61 |
10.20 |
72 |
Device |
0.29 |
- |
0 |
Diagnostic or lab test |
14.85 |
19.41 |
137 |
Diagnostic or lab results |
14.63 |
19.41 |
137 |
Receptor status |
0.22 |
- |
0 |
Demographics |
8.79 |
4.67 |
33 |
Age |
5.91 |
2.69 |
19 |
Special patient characteristic |
1.18 |
0.42 |
3 |
Literacy |
0.65 |
0.28 |
2 |
Gender |
0.41 |
1.27 |
9 |
Address |
0.35 |
- |
0 |
Ethnicity |
0.29 |
- |
0 |
Ethical Consideration |
8.52 |
8.64 |
61 |
Consent |
2.76 |
2.55 |
18 |
Enrolment in other studies |
2.38 |
1.27 |
9 |
Capacity |
1.50 |
3.54 |
25 |
Patient preference |
1.38 |
0.57 |
4 |
Compliance with protocol |
0.50 |
0.71 |
5 |
Lifestyle Choice |
3.38 |
1.56 |
11 |
Addictive behaviour |
2.09 |
1.42 |
10 |
Bedtime |
0.47 |
- |
0 |
Exercise |
0.44 |
- |
0 |
Diet |
0.38 |
0.14 |
1 |
no fitting category | - | 3.12 | 22 |
Detailed legend: Distribution of the 706 patient characteristics from 15 clinical trials according to the semantic categories developed by Luo et al. and comparison with the distribution obtained by Luo et al. for 4821 eligibility criteria.